Azenta Acquires UK Biocentre Limited to Expand European Biorepository Capabilities

Azenta, Inc. Acquires Ziath, Ltd.

February 3, 2023

Medical Devices

Azenta, Inc. (Nasdaq: AZTA) has acquired Ziath, Ltd., a Cambridge, UK–based provider of 2D barcode readers for life sciences laboratory applications. Ziath will join Azenta's Life Sciences Products business (Consumables and Instruments); CEO and co-founder Neil Benn will continue to lead the business, and the deal is expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.

Bruker Corporation Acquires ZONTAL Inc.

May 8, 2023

Software

Bruker Corporation has closed the acquisition of ZONTAL Inc., a provider of a GxP-compliant life-sciences data platform, to strengthen Bruker BioSpin's Integrated Data Solutions (IDS) software portfolio. The deal (terms not disclosed) will integrate ZONTAL's vendor-agnostic laboratory and process data management capabilities with Bruker's Mestrelab, Arxspan and Optimal offerings to accelerate digital laboratory transformation for biopharma and life-science customers; ZONTAL expected 2023 revenues of greater than $5 million.

AstraZeneca to Acquire EsoBiotec

March 18, 2025

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company developing in vivo cell therapies. The deal is valued at up to $1 billion on a cash and debt-free basis, with an initial $425 million payment upon closing plus up to $575 million in contingent milestone consideration. The transaction is expected to close in Q2 2025, subject to regulatory approvals.

Biotage AB Acquires ATDBio

October 20, 2021

Biotechnology

Swedish life sciences company Biotage AB has acquired UK-based oligonucleotide specialist ATDBio for approximately £45 million in cash and shares. The deal brings ATDBio’s complex DNA/RNA synthesis capabilities and its founders into the Biotage Group to accelerate capability expansion and scale molecular diagnostics, therapeutics and sequencing support services.

Zydus Lifesciences Acquires Agenus' U.S. Biologics Manufacturing Facilities and Launches Zylidac Bio LLC

January 16, 2026

Biotechnology

Zydus Lifesciences Limited has completed purchase agreements with Agenus Inc. to acquire Agenus' biologics manufacturing facilities and operations in Emeryville and Berkeley, California, and has established a U.S. CDMO subsidiary, Zylidac Bio LLC, to operate the assets. The deal includes exclusive manufacturing arrangements for Agenus' Phase 3 immuno-oncology candidates (botensilimab and balstilimab), exclusive commercialization rights for those assets in India and Sri Lanka, and an equity investment in Agenus via Zynext Ventures; regulatory approvals including CFIUS clearance were secured.

Pharmaron Acquires 82.54% of Biortus Biosciences

October 28, 2025

Healthcare Services

Pharmaron Beijing Co., Limited has entered into a definitive Share Purchase Agreement to acquire 82.54% of Biortus Biosciences Co., Ltd. and its affiliates. The transaction is expected to close after satisfaction of customary closing conditions and is intended to strengthen Pharmaron’s structure-based drug discovery and protein science capabilities.